Literature DB >> 1268470

A study of concentrations of trimethoprim-sulphamethoxazole in the human prostate gland.

N F Dabhoiwala, A Bye, M Claridge.   

Abstract

The ability of trimethoprim (TMP) and sulphamethoxazole (SMX) components of co-trimoxazole to penetrate the human prostate gland was investigated. After a single 4-tablet dose TMP was evenly distributed between prostate and plasma, whereas SMX was mainly associated with plasma. Following a week's therapy significant accumulation of TMP was seen in the prostate relative to plasma whereas SMX although still associated with plasma had increased drug levels in prostate compared with the single dose study. It is concluded that co-trimoxazole produces effective antibacterial levels in the human prostate and has indications in the treatment of prostatitis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1268470     DOI: 10.1111/j.1464-410x.1976.tb02748.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  8 in total

1.  The optimum pH for the derivative spectrophotometric determination of co-trimoxazole in binary mixtures.

Authors:  R O Adome; S Balyejjusa
Journal:  Afr Health Sci       Date:  2002-12       Impact factor: 0.927

2.  The treatment of chronic bacterial prostatitis.

Authors:  A Pfau
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 3.  Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

4.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

5.  Moxalactam concentrations in human prostatic tissue.

Authors:  R P Smith; H Wilbur; N T Sutphen; A L Baltch
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

Review 6.  The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues.

Authors:  D S Reeves; P J Wilkinson
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 7.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

Review 8.  Prostatitis.

Authors:  T A Stamey
Journal:  J R Soc Med       Date:  1981-01       Impact factor: 18.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.